JC
AGN

JBF Capital’s Allergan plc AGN Stock Holding History

JBF Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,000
Closed -$205K – 70
2017
Q3 		$205K Hold
1,000
– – 0.02% 37
2017
Q2 		$243K Hold
1,000
– – 0.03% 51
2017
Q1 		$239K Hold
1,000
– – 0.03% 48
2016
Q4 		$210K Hold
1,000
– – 0.03% 44
2016
Q3 		$230K Hold
1,000
– – 0.03% 58
2016
Q2 		$231K Hold
1,000
– – 0.03% 72
2016
Q1 		$268K Hold
1,000
– – 0.03% 73
2015
Q4 		$313K Hold
1,000
– – 0.04% 64
2015
Q3 		$272K Buy
+1,000
New +$307K 0.04% 73

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

JBF Capital's AGN Position: Q4 2017 in Review

JBF Capital sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,000 shares — an estimated $205K sold.

JBF Capital first reported a position in AGN in Q3 2015 and held it in 9 quarters. The position peaked at $313K in Q4 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • JBF Capital reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • JBF Capital sold 1,000 Allergan plc shares in Q4 2017, an estimated $205K.
  • JBF Capital first reported a position in Allergan plc in Q3 2015 and held it in 9 quarters.
  • JBF Capital's Allergan plc position peaked at $313K in Q4 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on JBF Capital's 13F filing for Q4 2017, filed 7 Feb 2018.